article thumbnail

Testa Center Automates Pharmaceutical Innovation

Automation World

A collaborative project between Rockwell Automation and Cytiva combines biomanufacturing and automation to create a scalable platform for the pharmaceutical industry’s digital transformation.

article thumbnail

Expansion of Pharmaceutical Production Drives Automation Use

Automation World

PMMI research highlights how the pharma industry’s efforts to modernize technology and automate at greater levels are being driven by ongoing supply chain issues and plans to provide more sustainable packaging.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Global pharmaceutical manufacturer arriving in South Australia

Manufacturer's Monthly

Global pharmaceutical company, Noumed, has made groundbreaking construction towards its $100 million pharmaceutical manufacturing facility at Salisbury, creating 250 construction jobs and 180 ongoing jobs upon completion.

article thumbnail

Using Sensors & IoT for Pharmaceutical Manufacturing

ATS

Share Pharmaceutical manufacturing operations are challenging environments for asset maintenance. IoT in pharmaceutical manufacturing supports predictive maintenance strategies that lower costs while raising OEE. This digitalization is part of a wider trend within pharmaceutical production that some have dubbed Pharma 4.0.

article thumbnail

Creating intelligence in the pharmaceutical supply chain.

Manufacturing & Logistics IT

Covid-19 is straining supply chains around the world, most notably those of pharmaceutical companies. Scarcity of raw materials upstream and overheated demand downstream cause disruptions. Control over their supply chain is a major challenge for all pharma companies today.

article thumbnail

EU regulation lacks consideration of pharmaceutical industry emissions

E&T

The study has described the current regulation of pharmaceutical companies as being unable to prevent the release of chemicals into the environment throughout the manufacturing supply chain. Moreover, in the EU, it is not possible to refuse the marketing authorisation of human pharmaceuticals based on environmental reasons.

article thumbnail

Fusion Pharmaceuticals to be acquired by AstraZeneca

Canadian Manufacturing

HAMILTON and BOSTON — Fusion Pharmaceuticals Inc., Fusion Pharmaceuticals says that RCs have emerged as a promising modality in cancer treatment over recent years.